Ayuso, Jose M.
Virumbrales-Muñoz, María
Lang, Joshua M. http://orcid.org/0000-0002-0943-8872
Beebe, David J. http://orcid.org/0000-0002-0415-9006
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R33CA225281, 3P30CA014520-46S2, 1-UG3-TR-003280-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health (UG3CACA260692)
U.S. Department of Defense (W81XWH-16-1-0514)
Article History
Received: 6 October 2021
Accepted: 28 April 2022
First Online: 2 June 2022
Competing interests
: D.J. Beebe holds equity in Bellbrook Labs LLC, Tasso Inc., Stacks to the Future LLC, Lynx Biosciences LLC, Onexio Biosystems LLC, Turba LLC, Flambeau Diagnostics LLC, and Salus Discovery LLC. D.J.J. Lang holds equity in Salus Discovery LLC. J.M. Lang holds equity in Salus Discovery LLC. Lang financial interests: Pfizer (Advisory Board, Personal), Janssen (Advisory Board, Personal), Gilead (Advisory Board, Personal), 4D Pharma (Advisory Board, Personal), Arvinas (Advisory Board, Personal), Astellas (Advisory Board, Personal), Myovant (Advisory Board, Personal), AstraZeneca (Advisory Board, Personal), SeaGen (Advisory Board, Personal). J.M. Ayuso and M. Virumbrales-Muñoz declare no competing interests.